143 related articles for article (PubMed ID: 23360698)
1. Evolution of taxanes in the treatment of metastatic breast cancer.
Binder S
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():9-14. PubMed ID: 23360698
[TBL] [Abstract][Full Text] [Related]
2. Metastatic breast cancer epidemiology and management with a focus on taxanes.
Donovan D
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():5-8. PubMed ID: 23360697
[TBL] [Abstract][Full Text] [Related]
3. Taxanes as a first-line systemic treatment in metastatic breast cancer.
Urquhart LM
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():15-21. PubMed ID: 23360699
[TBL] [Abstract][Full Text] [Related]
4. nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial.
Dranitsaris G; Coleman R; Gradishar W
Breast Cancer Res Treat; 2010 Feb; 119(3):717-24. PubMed ID: 19495958
[TBL] [Abstract][Full Text] [Related]
5. An economic evaluation of docetaxel and paclitaxel regimens in metastatic breast cancer in the UK.
Benedict A; Cameron DA; Corson H; Jones SE
Pharmacoeconomics; 2009; 27(10):847-59. PubMed ID: 19803539
[TBL] [Abstract][Full Text] [Related]
6. Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer.
Dranitsaris G; Cottrell W; Spirovski B; Hopkins S
J Oncol Pharm Pract; 2009 Jun; 15(2):67-78. PubMed ID: 19036903
[TBL] [Abstract][Full Text] [Related]
7. Taxanes in the treatment of early breast cancer.
Ring AE; Ellis PA
Cancer Treat Rev; 2005 Dec; 31(8):618-27. PubMed ID: 16266787
[TBL] [Abstract][Full Text] [Related]
8. Taxanes: impact on breast cancer therapy.
Bachegowda LS; Makower DF; Sparano JA
Anticancer Drugs; 2014 May; 25(5):512-21. PubMed ID: 24552749
[TBL] [Abstract][Full Text] [Related]
9. Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin-bound paclitaxel.
Petrelli F; Borgonovo K; Barni S
Expert Opin Pharmacother; 2010 Jun; 11(8):1413-32. PubMed ID: 20446855
[TBL] [Abstract][Full Text] [Related]
10. Special considerations in the management of older adult patients with metastatic breast cancer.
Donovan D
Clin J Oncol Nurs; 2013 Feb; 17 Suppl():41-8. PubMed ID: 23360702
[TBL] [Abstract][Full Text] [Related]
11. Taxanes in the treatment of breast cancer: a prodigy comes of age.
Miller KD; Sledge GW
Cancer Invest; 1999; 17(2):121-36. PubMed ID: 10071597
[TBL] [Abstract][Full Text] [Related]
12. Weekly paclitaxel versus weekly docetaxel in elderly or frail patients with metastatic breast carcinoma: a randomized phase-II study of the Belgian Society of Medical Oncology.
Beuselinck B; Wildiers H; Wynendaele W; Dirix L; Kains JP; Paridaens R
Crit Rev Oncol Hematol; 2010 Jul; 75(1):70-7. PubMed ID: 19651523
[TBL] [Abstract][Full Text] [Related]
13. Use and abuse of taxanes in the management of metastatic breast cancer.
Bernard-Marty C; Cardoso F; Piccart MJ
Eur J Cancer; 2003 Sep; 39(14):1978-89. PubMed ID: 12957452
[TBL] [Abstract][Full Text] [Related]
14. [The role of taxanes in breast cancer chemotherapy: what's new 15 years after?].
Herceg D; Vrbanec D
Lijec Vjesn; 2009; 131(5-6):133-41. PubMed ID: 19642533
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and docetaxel in the treatment of breast cancer.
Saloustros E; Mavroudis D; Georgoulias V
Expert Opin Pharmacother; 2008 Oct; 9(15):2603-16. PubMed ID: 18803448
[TBL] [Abstract][Full Text] [Related]
16. Taxanes in elderly breast cancer patients.
Wildiers H; Paridaens R
Cancer Treat Rev; 2004 Jun; 30(4):333-42. PubMed ID: 15145508
[TBL] [Abstract][Full Text] [Related]
17. Docetaxel in anthracycline-resistant metastatic breast cancer.
Hui YF; Ignoffo RJ
Cancer Pract; 1997; 5(2):124-7. PubMed ID: 9110651
[TBL] [Abstract][Full Text] [Related]
18. Docetaxel in the treatment of breast cancer: current experience and future prospects.
Nabholtz JM; Gligorov J
Expert Rev Anticancer Ther; 2005 Aug; 5(4):613-33. PubMed ID: 16111463
[TBL] [Abstract][Full Text] [Related]
19. Weekly nab-paclitaxel is safe and effective in ≥65 years old patients with metastatic breast cancer: a post-hoc analysis.
Aapro M; Tjulandin S; Bhar P; Gradishar W
Breast; 2011 Oct; 20(5):468-74. PubMed ID: 21843943
[TBL] [Abstract][Full Text] [Related]
20. Treatment innovations for metastatic breast cancer: nanoparticle albumin-bound (NAB) technology targeted to tumors.
Lluch A; Alvarez I; Muñoz M; Seguí MÁ; Tusquets I; García-Estévez L
Crit Rev Oncol Hematol; 2014 Jan; 89(1):62-72. PubMed ID: 24071503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
